Cargando…

Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

Detalles Bibliográficos
Autores principales: Ailani, Jessica, McAllister, Peter, Winner, Paul K., Chakhava, George, Josiassen, Mette Krog, Lindsten, Annika, Sperling, Bjørn, Ettrup, Anders, Cady, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481482/
https://www.ncbi.nlm.nih.gov/pubmed/37674117
http://dx.doi.org/10.1186/s12883-023-03368-3
_version_ 1785101984032882688
author Ailani, Jessica
McAllister, Peter
Winner, Paul K.
Chakhava, George
Josiassen, Mette Krog
Lindsten, Annika
Sperling, Bjørn
Ettrup, Anders
Cady, Roger
author_facet Ailani, Jessica
McAllister, Peter
Winner, Paul K.
Chakhava, George
Josiassen, Mette Krog
Lindsten, Annika
Sperling, Bjørn
Ettrup, Anders
Cady, Roger
author_sort Ailani, Jessica
collection PubMed
description
format Online
Article
Text
id pubmed-10481482
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104814822023-09-07 Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial Ailani, Jessica McAllister, Peter Winner, Paul K. Chakhava, George Josiassen, Mette Krog Lindsten, Annika Sperling, Bjørn Ettrup, Anders Cady, Roger BMC Neurol Correction BioMed Central 2023-09-06 /pmc/articles/PMC10481482/ /pubmed/37674117 http://dx.doi.org/10.1186/s12883-023-03368-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Ailani, Jessica
McAllister, Peter
Winner, Paul K.
Chakhava, George
Josiassen, Mette Krog
Lindsten, Annika
Sperling, Bjørn
Ettrup, Anders
Cady, Roger
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
title Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
title_full Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
title_fullStr Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
title_full_unstemmed Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
title_short Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
title_sort correction: rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized relief trial
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481482/
https://www.ncbi.nlm.nih.gov/pubmed/37674117
http://dx.doi.org/10.1186/s12883-023-03368-3
work_keys_str_mv AT ailanijessica correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT mcallisterpeter correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT winnerpaulk correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT chakhavageorge correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT josiassenmettekrog correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT lindstenannika correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT sperlingbjørn correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT ettrupanders correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial
AT cadyroger correctionrapidresolutionofmigrainesymptomsafterinitiatingthepreventivetreatmenteptinezumabduringamigraineattackresultsfromtherandomizedrelieftrial